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Nosocomial dissemination of glycopeptide-resistant enterococci rep-
resents a major problem in hospitals worldwide. In Brazil, the dissemi-
nation among hospitals in the city of São Paulo of polyclonal DNA
profiles was previously described for vancomycin-resistant Entero-
coccus faecium. We describe here the dissemination of VanA pheno-
type E. faecalis between two hospitals located in different cities in the
State of São Paulo. The index outbreak occurred in a tertiary care
university hospital (HCUSP) in the city of São Paulo and three years
later a cluster caused by the same strain was recognized in two patients
hospitalized in a private tertiary care hospital (CMC) located 100 km
away in the interior of the state. From May to July 1999, 10 strains of
vancomycin-resistant E. faecalis were isolated from 10 patients hospi-
talized in the HCUSP. The DNA genotyping using pulsed-field gel
electrophoresis (PFGE) showed that all isolates were originated from
the same clone, suggesting nosocomial dissemination. From May to
July 2002, three strains of vancomycin-resistant E. faecalis were
isolated from two patients hospitalized in CMC and both patients were
colonized by the vancomycin-resistant Enterococcus in skin lesions.
All isolates from CMC and HCUSP were highly resistant to vancomy-
cin and teicoplanin. The three strains from CMC had minimum
inhibitory concentration >256 µg/ml for vancomycin, and 64 (CMC 1
and CMC 2) and 96 µg/ml (CMC 3) for teicoplanin, characterizing a
profile of VanA resistance to glycopeptides. All strains had the
presence of the transposon Tn1546 detected by PCR and were closely
related when typed by PFGE. The dissemination of the E. faecalis
VanA phenotype among hospitals located in different cities is of great
concern because E. faecalis commonly colonizes the gastrointestinal
tract of patients and healthy persons for periods varying from weeks to
years, which, together with the persistence of vancomycin-resistant
Enterococcus in hospital rooms after standard cleaning procedures,
increases the risk of the dissemination and reservoir of the bacteria.
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Nosocomial infections caused by glyco-
peptide-resistant Enterococcus spp are a
growing problem in hospitals worldwide.
Since the first cases of vancomycin-resistant
Enterococcus (VRE) were described in 1988
(1,2) an increasing number of cases have
been reported in several hospitals in the
world (3,4), including Brazil (5). The molec-
ular epidemiology of VRE has shown that a
single predominant strain was recovered in
hospital settings right after the first identifi-
cation of VRE (6,7) and a polyclonal profile
was reported in hospitals where VRE had
been present for some time (8,9). The VanA
phenotype VRE strains are typically highly
resistant to vancomycin and moderately to
highly resistant to teicoplanin (10). Induc-
ible resistance to high levels of vancomycin
and teicoplanin is mediated by the transpo-
son Tn1546 or closely related elements (11).
In the present investigation, we studied the
inter-hospital dissemination of VanA-type
E. faecalis strains that occurred between two
hospitals located in two different cities 100
km apart in the State of São Paulo, Brazil.
Hospitals settings. Centro Médico de
Campinas (CMC) is a private tertiary care
hospital located in Campinas, SP, and 100
km from the capital of the State of São Paulo.
Hospital das Clínicas of the University of
São Paulo (HCUSP) is a tertiary care teach-
ing hospital associated with the University
Medical School with approximately 2000
beds and is the main reference hospital in
São Paulo, a city of approximately 11 mil-
lion inhabitants.
E. faecalis vancomycin-resistant clinical
isolates. From May to July 1999, 10 vanco-
mycin-resistant strains of E. faecalis were
isolated from 10 patients admitted to HCUSP.
Vancomycin-resistant E. faecalis was iso-
lated from urine (N = 6), from a central
venous catheter (N = 1), from feces (N = 1),
and from bronchoalveolar lavage (N = 1).
The DNA genotyping by pulsed-field gel
electrophoresis (PFGE) showed that all iso-
lates originated from the same clone, sug-
gesting nosocomial dissemination (12).
From May to July 2002, 3 strains of
vancomycin-resistant E. faecalis were iso-
lated from 2 patients hospitalized at CMC
and both patients were colonized by VRE in
skin lesions. All isolates were tested for
susceptibility to vancomycin and teicopla-
nin using the Etest® and minimum inhibitory
concentrations (MIC) were determined ac-
cording to the NCMLS document M100-
S10(M7) 2000 (13).
Control strains of E. faecalis. During the
period from 1999 to 2002, 60 strains of
vancomycin-susceptible E. faecalis stored
in 10% skim milk at -20ºC were included in
the present study as control strains for DNA
typing by PFGE. These strains were isolated
from patients with bloodstream infections
admitted to CMC.
Detection of transposon Tn1546. Tn1546
was detectd by PCR based on the method of
Martineau et al. (14). The isolates were cul-
tured in BHI broth and 2 µl of 0.5 McFarland
solution of the bacterial suspension was trans-
ferred to a PCR solution with a 50-µl final
volume (2.5 mM MgCl2, 0.1% Triton X-100,
2.5 mM dNTP, 2.5 U Taq polymerase, 50
pmol of each primer: 5’TTA TAA CCG
TTC CCG CAG AC and 5’GAA ACC CAG
ATT GA). PCR conditions were: 3 min at
92ºC, 30 cycles of denaturation at 92ºC for 1
min, annealing temperature at 60ºC and ex-
tension at 72ºC for 1 min, and a final exten-
sion at 72ºC for 3 min. PCR products were
electrophoresed on 1.5% agarose gel. The
primers were designed on the basis of the
Tn1546 sequence deposited in Genbank un-
der accession number M97297.
Genomic DNA typing by PFGE. DNA
extraction was performed as previously de-
scribed (15). The genetic relatedness among
the strains was interpreted by the method of
Tenover et al. (12) and isolates with identi-
cal or related PFGE patterns were consid-
ered to be derived from a common clone.
The genetic relationship among PFGE pat-
terns was also analyzed by computer soft-
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ware after capturing the autoradiographic
images with an IS-1000 digital imaging sys-
tem (Bio-Capt MW, version 99; M&S In-
struments Trading Inc., Marne-la Valle,
France). The dendrogram of the PFGE pat-
terns was generated using the Dice coeffi-
cient (Biogene software; Vilbert-Loumart,
Marne-la-Valle, France).
All isolates from CMC and HCUSP were
highly resistant to vancomycin and teicopla-
nin. The three strains from CMC had MIC
>256 µg/ml for vancomycin, and 64 (CMC 1
and CMC 2) and 96 µg/ml (CMC 3) for
teicoplanin, characterizing a profile of VanA
resistance to glycopeptides.
The genomic DNA profiles obtained by
PFGE revealed that all strains from HCUSP
had the same profile, which was closely
related (derived from the same clone, ac-
cording to Tenover et al., 12) to that of the
strains from CMC (Figure 1). Comparison of
the E. faecalis strains from the two hospitals
showed that the CMC strains were closely
related to those from HCUSP, suggesting
that they came from the same clone. The
relationship among the E. faecalis strains
shown in the dendrogram (Figure 2) demon-
strated that the strains from the hospitals
were 95% related. Among the E. faecalis
control strains, we found one clone with
three strains possibly related to the VanA-
resistant strains.
All vancomycin-resistant strains were
submitted to PCR amplification of the 168-
bp fragment corresponding to Tn1546 (Fig-
ure 3), characterizing the VanA phenotype
of the strains from both hospitals. The three
vancomycin-susceptible isolates possibly
related to the VRE clone had no amplifica-
tion of the 168-bp fragment.
Since the identification of cases of VanA-
resistant Enterococci in Brazil (16,17), sub-
sequent cases and nosocomial dissemination
of VRE were described in the city of São
Paulo, especially related to the E. faecium
VanA phenotype (5). Zanella et al. (18) de-
scribed the characterization of a large group
Figure 1. PFGE of Enterococcus faecalis. Lane 1, Molecular weight lambda ladder size
marker (kb); lane 2, E. faecalis ATCC 29212; lanes 3 to 5, vancomycin-resistant E. faecalis
isolated from Hospital das Clínicas, Universidade de São Paulo; lanes 6 to 8, vancomycin-
resistant E. faecalis from Centro Médico de Campinas; lanes 9 to 11, vancomycin-suscep-
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Figure 2. Dendrogram of Enterococcus faecalis VanA phenotype. The values were gener-
ated from the Dice coefficient showing the similarity of E. faecalis vancomycin-resistant
strains from Centro Médico de Campinas (CMC), Hospital das Clínicas, Universidade de
São Paulo (HCUSP) and vancomycin-susceptible E. faecalis from Universidade Estadual
de Campinas (UNICAMP).
of VRE in Brazil during the investigation of
a nosocomial outbreak in a general hospital
in the city of São Paulo. However, inter-
hospital dissemination of the E. faecalis
VanA phenotype seemed to be less common
than dissemination of the E. faecium VanA
phenotype.







Braz J Med Biol Res 37(9) 2004
M.L. Moretti et al.
The molecular typing study of the VRE
isolated in 1999 from HCUSP showed intra-
hospital dissemination. The emergence of
the two cases of VRE in the hospital in
Campinas indicated a possible inter-hospital
dissemination. DNA typing showed that the
two clusters were closely related and strongly
suggests an inter-hospital dissemination in-
volving the spread of VRE in different cities
in Brazil. Of note, the cluster in CMC oc-
curred three years after the detection of the
VRE cases in HCUSP.
The origin of VRE in CMC was unclear
but appeared to have been imported from
HCUSP. The strains were closely related
genomically, suggesting intra-hospital dissemi-
nation. A previous study on intra-hospital VRE
dissemination involved E. faecium strains from
6 medical centers in São Paulo, showing a
polyclonal DNA profile and intra-hospital dis-
semination in the city of São Paulo (5). How-
ever, the dissemination of the E. faecalis VanA
profile among hospitals involving different
cities in Brazil has not been described previ-
ously. This event is of great concern because
E. faecalis commonly colonizes the gastrointes-
tinal tract of patients and healthy persons for
periods varying from weeks to years (19); the
persistence of VRE in hospital rooms after
standard cleaning procedures increases the
risk of the dissemination and reservoir of the
bacteria (20).
Figure 3. Demonstration of transposon Tn1546 in vancomycin-resistant isolates of Entero-
coccus faecalis by PCR. The 168-bp product corresponded to the amplification of Tn1546.
Lane 1, Molecular weight in bp; lane 2, E. faecalis ATCC 29212; lanes 3 to 5, vancomycin-
resistant E. faecalis from Hospital das Clínicas, Universidade de São Paulo; lanes 6 to 8, E.
faecalis vancomycin resistant from Centro Médico de Campinas; lanes 9 to 11, E. faecalis
vancomycin-susceptible from Universidade Estadual de Campinas; lane 12, negative control.
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